Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$274K Sell
649
-15
-2% -$5.98K 0.17% 112
2026
Q2
$240K Buy
+664
New +$227K 0.15% 113

Other funds holding AMGN

Blue Capital's AMGN Position: Q3 2026 in Review

Blue Capital reduced its Amgen (AMGN) stake by 2.3% in Q3 2026, selling an estimated $5.98K and leaving 649 shares worth $274K. The position accounts for 0.17% of the portfolio, ranked #112.

Blue Capital first reported a position in AMGN in Q2 2026 and has held it in 2 quarters since. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Blue Capital held 649 shares of Amgen worth $274K as of Q3 2026.
  • Blue Capital sold 15 Amgen shares in Q3 2026, an estimated $5.98K.
  • Amgen made up 0.17% of Blue Capital's portfolio in Q3 2026, its #112 holding.
  • Blue Capital first reported a position in Amgen in Q2 2026 and has held it in 2 quarters since.
  • 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Blue Capital's 13F filing for Q3 2026, filed 13 Oct 2026.